Chemotherapeutic approaches for newly diagnosed hepatoblastoma: Past, present, and future strategies

Pediatric Blood and Cancer

Volumn 59, Issue 5, 2012, Pages 809-812

  Trobaugh Lotrario, Angela D ^a   Katzenstein, Howard M ^b  

^a Sacred Heart Children's Hospital   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Chemotherapy; Hepatoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; IRINOTECAN; POG 8697; UNCLASSIFIED DRUG; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; HEPATOBLASTOMA; HIGH RISK PATIENT; HUMAN; LIVER TRANSPLANTATION; METASTASIS; MULTIPLE CYCLE TREATMENT; OTOTOXICITY; OVERALL SURVIVAL; PREOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REVIEW; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FLUOROURACIL; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MALE; NEOPLASM METASTASIS; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84866170113     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24219     Document Type: Review

References (19)

1. Katzenstein HM, London WB, Douglass EC, et al. Treatment of unresectable and metastatic hepatoblastoma: A pediatric oncology group phase II study. J Clin Oncol 2002; 20: 3438-3444.
2. Perilongo G, Brown J, Shafford E, et al. Hepatoblastoma presenting with lung metastases: Treatment results of the first cooperative, prospective study of the international society of paediatric oncology on childhood liver tumors. Cancer 2000; 89: 1845-1853.
3. Zsiros J, Maibach R, Shafford E, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3hr study. J Clin Oncol 2010; 28: 2584-2590.
4. Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the international society of paediatric oncology-SIOPEL 2. Eur J Cancer 2004; 40: 411-421.
5. Black CT, Cangir A, Choroszy M, et al. Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma. J Pediatr Surg 1991; 26: 1070-1073.
6. Douglass EC, Green AA, Wrenn E, et al. Effective cisplatin (ddp) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 1985; 13: 187-190.
7. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the children's cancer group and the pediatric oncology group. J Clin Oncol 2000; 18: 2665-2675.
8. Perilongo G, Maibach R, Shafford E, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 2009; 361: 1662-1670.
9. Stringer MD, Hennayake S, Howard ER, et al. Improved outcome for children with hepatoblastoma. Br J Surg 1995; 82: 386-391.
10. Malogolowkin MH, Katzenstein HM, Meyers RL, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: A report from the children's oncology group. J Clin Oncol 2011; 29: 3301-3306.
11. Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, et al. Small cell undifferentiated variant of hepatoblastoma: Adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 2009; 52: 328-334.
12. Evans AE, Land VJ, Newton WA, et al. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982; 50: 821-826.
13. Douglass EC, Reynolds M, Finegold M, et al. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: A pediatric oncology group study. J Clin Oncol 1993; 11: 96-99.
14. Ortega JA, Krailo MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the childrens cancer study group. J Clin Oncol 1991; 9: 2167-2176.
15. Malogolowkin MH, Katzenstein H, Krailo MD, et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol 2006; 24: 2879-2884.
16. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma-Results from the international society of paediatric oncology (siop) study SIOPEL 1. Eur J Cancer 2000; 36: 1418-1425.
17. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American academy of pediatrics surgical section survey-1974. J Pediatr Surg 1975; 10: 329-337.
18. von Schweinitz D, Byrd DJ, Hecker H, et al. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study committee of the cooperative paediatric liver tumour study hb89 of the german society for paediatric oncology and haematology. Eur J Cancer 1997; 33: 1243-1249.
19. Fuchs J, Rydzynski J, Von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the german cooperative pediatric liver tumor study hb 94. Cancer 2002; 95: 172-182.